Akero Therapeutics (AKRO) had the highest return in September 2022 by a US stock with a market cap of $1B+, returning 184%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | September 2022 | 183.99% |
Enliven Therapeutics (ELVN) | September 2022 | 96.55% |
Pulse Biosciences (PLSE) | September 2022 | 79.69% |
Ideaya Biosciences (IDYA) | September 2022 | 50.71% |
Cricut (CRCT) | September 2022 | 50.32% |
Eve (EVEX) | September 2022 | 43.7% |
New Gold (NGD) | September 2022 | 40.58% |
NioCorp Developments Ltd Common Stock (NB) | September 2022 | 38.67% |
Biogen (BIIB) | September 2022 | 37.08% |
Harrow Health (HROW) | September 2022 | 34.56% |
89bio (ETNB) | September 2022 | 31.89% |
Intapp (INTA) | September 2022 | 30.65% |
Dyne Therapeutics (DYN) | September 2022 | 29.59% |
Compania de Minas Buenaventura SAA ADR (BVN) | September 2022 | 29.42% |
Janux Therapeutics (JANX) | September 2022 | 27.26% |
Wix (WIX) | September 2022 | 26.42% |
Coeur Mining (CDE) | September 2022 | 25.74% |
Immunitybio (IBRX) | September 2022 | 24.87% |
Ardelyx (ARDX) | September 2022 | 24.8% |
D-Wave Quantum (QBTS) | September 2022 | 24.33% |
Wave Life Sciences (WVE) | September 2022 | 24.05% |
Maravai Lifesciences Holdings (MRVI) | September 2022 | 23.33% |
International Seaways (INSW) | September 2022 | 21.17% |
PROS (PRO) | September 2022 | 21.14% |
Asana (ASAN) | September 2022 | 19.71% |
